In addition, 12-month changes in anti-CS and anti-TOPO-F4 IgM and IgG levels variably positively correlated with changes in CRP, RA, and AS disease activity, FMD, PWV, and ccIMT over time. The gene discussed is CRP; the disease is rheumatoid arthritis.